title: Paradoxical immune reconstitution inflammatory syndrome associated with rituximab-containing regimen in a patient with lymphoma.
authors: Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
authors: Jonathan
authors: J
authors: Canaani
authors: Sharon
authors: S
authors: Amit
authors: Jonathan
authors: J
authors: Ben-Ezra
authors: Mehrzad
authors: M
authors: Cohen Pour
authors: Nadav
authors: N
authors: Sarid
authors: Hedva
authors: H
authors: Lerman
authors: Chava
authors: C
authors: Perry
authors: Aaron
authors: A
authors: Polliack
authors: Elizabeth
authors: E
authors: Naparstek
authors: Yair
authors: Y
authors: Herishanu
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects / Q000276:immunology*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000276:immunology; D000995:Antitubercular Agents / Q000009:adverse effects / Q000276:immunology; D003937:Diagnosis, Differential; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000139:chemically induced / Q000175:diagnosis / Q000276:immunology*; D008223:Lymphoma / Q000188:drug therapy / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000276:immunology / Q000302:isolation & purification; D000069283:Rituximab; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000995:Antitubercular Agents; D000069283:Rituximab